The antidiuretic drugs market will register a CAGR of almost 10% by 2023

Tuesday, March 26, 2019 Drug News
Email Print This Page Comment bookmark
Font : A-A+

LONDON, March 25, 2019 /PRNewswire/ -- About this marketWith the rapid onset of modernization, the lifestyle of people

is also changing. The prevalence of such health conditions is rising globally due to the sedentary lifestyle. Furthermore, the high prevalence of conditions such as urinary incontinence and interstitial cystitis has been substantially contributing to
the global antidiuretic drugs market. According to the CDC, the prevalence of nocturia in the US during 2013-2014 was found to be nearly 25% of the population. and the prevalence rate increased to about 40% in the people affected with chronic kidney diseases. Such a high prevalence of chronic conditions leads to polyuria and nocturia, which, in turn, will help in driving the global antidiuretic drugs market. Analysts have predicted that the antidiuretic drugs market will register a CAGR of almost 10% by 2023.Download the full report: https://www.reportbuyer.com/product/5760306/?utm_source=PRN Market OverviewRising geriatric populationThe prevalence of chronic conditions that lead to various urologic diseases, including polyuria and nocturia, increases with age, and these conditions are prevalent in the geriatric population. Furthermore, rapid developments in the healthcare facilities and advanced treatment options have increased the life expectancy of the geriatric population globally. Rising awareness about various health conditions has been substantially contributing to the higher life expectancy.Stringent regulator policiesOne of the major challenges faced by the pharmaceutical vendors is the stringent policies set by various regulatory bodies and governing authorities globally. The US FDA has increased the regulatory surveillance for the drugs treating rare diseases, to avoid any associated risks. Hence, the disappointing results in drugs performance lead to the postponement of marketing approvals, which, further hampers the market growth.For the detailed list of factors that will drive and challenge the growth of the antidiuretic drugs market during the 2019-2023, view our report.Download the full report: https://www.reportbuyer.com/product/5760306/?utm_source=PRN About Reportbuyer Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers For more information: Sarah Smith Research Advisor at Reportbuyer.com Email: sarah@reportbuyer.com Tel: +1 (718) 213 4904 Website: www.reportbuyer.com

Cision View original content:http://www.prnewswire.com/news-releases/the-antidiuretic-drugs-market-will-register-a-cagr-of-almost-10-by-2023-300817933.html

SOURCE ReportBuyer



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store